Showing results (401-410 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|July 6, 2016
Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodiesPatrick M Glassman, Joseph P BalthasarJournal of Pharmacokinetics and Pharmacodynamics|January 8, 2018
Boolean network modeling in systems pharmacologyPeter Bloomingdale, Van Anh Nguyen, Jin Niu, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 14, 2018
Correction to: Scientific white paper on concentration-QTc modelingChristine Garnett, Peter L Bonate, Qianyu Dang, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 11, 2018
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic modelDwaipayan Mukherjee, Jiuhong Zha, Rajeev M Menon, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 14, 2018
A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature dataSamantha H Dallefeld, Andrew M Atz, Ram Yogev, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 24, 2008
Comparison of proportional and differential odds models for mixed-effects analysis of categorical dataMaria C Kjellsson, Per-Henrik Zingmark, E Niclas Jonsson, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 14, 2008
Approximations of the target-mediated drug disposition model and identifiability of model parametersLeonid Gibiansky, Ekaterina Gibiansky, Tarundeep Kakkar, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 17, 2009
The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusionHanna E Silber, Maria C Kjellsson, Mats O KarlssonJournal of Pharmacokinetics and Pharmacodynamics|October 2, 2007
Mechanism-based pharmacokinetic-pharmacodynamic modeling of antimicrobial drug effectsDavid Czock, Frieder KellerJournal of Pharmacokinetics and Pharmacodynamics|July 18, 2008
Population PK-PD model for Fc-osteoprotegerin in healthy postmenopausal womenMatthew L Zierhut, Marc R Gastonguay, Steven W Martin, et al.Pageof 107